Bromine in PDB 5rzz: EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220

The structure of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220, PDB code: 5rzz was solved by W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	38.58 / 1.76
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	38.530, 77.100, 99.570, 90.00, 90.00, 90.00
R / Rfree (%)	21.1 / 25.2

The binding sites of Bromine atom in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220 (pdb code 5rzz). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220, PDB code: 5rzz:

Bromine binding site 1 out of 1 in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1551999220 within 5.0Å range: probe atom residue distance (Å) B Occ A:Br401 b:44.1 occ:0.52 BR A:WJJ401 0.0 44.1 0.5 C6 A:WJJ401 1.9 41.9 0.5 C5 A:WJJ401 2.8 43.8 0.5 C7 A:WJJ401 2.9 41.2 0.5 O A:LEU320 3.5 29.3 1.0 CA A:GLY319 3.6 25.2 1.0 N A:GLY319 3.7 25.4 1.0 C A:GLY319 3.7 23.3 1.0 N A:LEU320 3.7 25.8 1.0 CB A:ARG331 3.8 39.0 0.5 O A:PHE332 3.8 34.3 1.0 N A:PHE332 3.9 36.4 1.0 CG A:LEU321 3.9 33.5 1.0 C A:LEU320 4.0 28.9 1.0 C A:SER318 4.0 33.1 1.0 CD2 A:LEU321 4.0 39.1 1.0 C A:PHE332 4.0 33.7 1.0 OG A:SER318 4.0 44.6 1.0 CA A:ARG331 4.1 38.0 0.5 C4 A:WJJ401 4.1 46.1 0.5 C8 A:WJJ401 4.2 44.1 0.5 N A:ALA333 4.2 37.2 1.0 O A:SER318 4.2 36.6 1.0 C A:ARG331 4.2 37.0 0.5 O A:GLY319 4.2 24.6 1.0 CG A:ARG331 4.5 39.7 0.5 CA A:LEU320 4.5 25.9 1.0 CA A:ALA333 4.5 37.5 1.0 CB A:SER318 4.6 36.6 1.0 N A:LEU321 4.6 24.8 1.0 CD1 A:LEU321 4.7 36.9 1.0 CA A:PHE332 4.7 38.7 1.0 CD A:ARG331 4.7 41.4 0.5 C3 A:WJJ401 4.7 47.2 0.5 SG A:CYS316 4.8 30.5 1.0 CA A:SER318 4.9 33.8 1.0 CA A:LEU321 4.9 27.4 1.0

W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi. EPB41L3 Pandda Analysis Group Deposition To Be Published.